ArticleQuantitative imaging in medicine and surgery2025
Analysis of the effects of cystic cavity flushing with lidocaine during ultrasound-guided anhydrous ethanol sclerotherapy in the treatment of ovarian endometrioma.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Efficacy and Safety of Dehydrated Alcohol Versus Lauromacrogol for Sclerotherapy of Simple Renal Cysts: A Retrospective Comparison Study.Health science reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ultrasound-guided anhydrous ethanol sclerotherapy (UGAES) is an effective treatment option for ovarian endometrioma-related pain and infertility. However, its use is limited by the fact that alcohol can sometimes cause unbearable abdominal pain. This study aimed to use different concentrations of lidocaine solution for cystic cavity flushing to assess its pain-relieving effect, and to investigate its effect on treatment efficacy and the degree of improvement in clinical symptoms. Methods: This retrospective cohort study included 90 patients who underwent UGAES of ovarian endometriosis cysts from January 2022 to June 2024 at Zhejiang Hospital. The patients were allocated to the lidocaine group (comprising 61 patients) and the non-lidocaine group (comprising 29 patients) based on the use of lidocaine. The lidocaine group was further subdivided into four subgroups of 0.25%, 0.33%, 0.50%, and 1.00% depending on the concentration of lidocaine. Intraoperative pain scores (IPSs) were assessed by visual analogue scoring. At the three-month follow-up, the degree of improvement in clinical symptoms was assessed using the Clinical Symptom Scores (CSSs), and efficacy was assessed by repeat ultrasonography to calculate the cyst volume reduction ratio (VRR). Results: A total of 90 cysts were collected from 90 patients (mean age: 29.50±6.58 years; range, 18-47 years). The patients in the lidocaine group had significantly lower IPSs than those in the non-lidocaine group [2 (IQR, 2, 3) Conclusions: The use of lidocaine in the intracavitary irrigation of cysts effectively reduces patients' intraoperative pain during UGAES. Different dilution concentrations of lidocaine did not have a significant effect on the therapeutic efficacy. These findings provide a new clinical strategy for pain management and may contribute to the improvement of patients' treatment experience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.